Efficacy of Valproic Acid Against Coronavirus Disease 2019 Infection or Severity: A Pilot Study

∗Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

†Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA.

Address correspondence and reprint requests to Mohsen Farazdaghi, MD, Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; E-mail: [email protected]; [email protected]; [email protected]; [email protected]

ORCID Numbers: https://orcid.org/0000-0002-2598-7601 (A.A.A.-P.); https://orcid.org/0000-0003-4765-686X (M.F.).

Conflicts of Interest and Source of Funding: A.A.A.-P. has received honoraria from Cobel Daruo, Tekaje, Sanofi, and RaymandRad; royalty from Oxford University Press (book publication); and a grant from the National Institute for Medical Research Development. The other authors have no conflicts of interest to declare.

This work was supported by the Shiraz University of Medical Sciences. The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Authors' contributions: A.A.A.-P.: study design, data collection, statistical analyses, and manuscript preparation; M.F.: statistical analyses, data collection, and manuscript preparation; other authors: data collection and manuscript preparation.

Availability of data and material: The data used in this study are confidential and will not be shared.

None of the authors listed on the article are employed by a government agency. All are academicians. None of the authors are submitting this article as an official representative or on behalf of the government.

Comments (0)

No login
gif